Immediate Impact
14 standout
Citing Papers
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023 Standout
Works of Libor Staněk being referenced
Comparison of immunohistochemistry, four in situ hybridization methods and quantitative polymerase chain reaction for the molecular diagnosis of HER2 status in gastric cancer: A study of 55 cases
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Libor Staněk | 15 | 4 | 16 | 28 | 22 | 7 | 62 | |
| A Ardizzone | 29 | 5 | 5 | 12 | 16 | 7 | 60 | |
| Romerai D’Amico | 9 | 14 | 15 | 20 | 10 | 7 | 46 | |
| Bruce Levin | 7 | 9 | 4 | 37 | 24 | 6 | 83 | |
| María Urbanowicz | 11 | 18 | 12 | 14 | 14 | 9 | 55 | |
| Taymaa May | 7 | 5 | 3 | 12 | 20 | 6 | 54 | |
| Aruyaru Stanley Mwenda | 16 | 4 | 4 | 15 | 8 | 9 | 56 | |
| Ilka Kolodziej | 6 | 20 | 7 | 39 | 16 | 5 | 48 | |
| M. Panadés | 14 | 19 | 22 | 24 | 10 | 7 | 55 | |
| A. Casado Herráez | 21 | 7 | 11 | 13 | 19 | 9 | 57 | |
| Sunanda Dhar | 6 | 11 | 3 | 30 | 41 | 5 | 58 |
All Works
Loading papers...